CURIUM UND PIUR IMAGING KÜNDIGEN EINE PARTNERSCHAFT FÜR DIE SCHILDDRÜSENBILDGEBUNG IN DEUTSCHLAND AN, UM TOMOGRAPHISCHE 3D-ULTRASCHALLÖSUNGEN ZU ERMÖGLICHEN
October 25, 2023 07:33 ET
|
Curium
BERLIN, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Curium, ein weltweit führendes Unternehmen in der Nuklearmedizin, und PIUR IMAGING, ein europäisches Medizintechnikunternehmen, das bei der Entwicklung von...
Curium and PIUR IMAGING Announce Thyroid Imaging Partnership in Germany to Enable Tomographic 3D Ultrasound Solutions
October 25, 2023 07:33 ET
|
Curium
BERLIN, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, and PIUR IMAGING, a European medical device company at the forefront of pioneering tomographic 3D ultrasound...
Non-Invasive Cancer Diagnostics Market Size & Share Surpass USD 207 billion by 2031, Growing at a CAGR of 7.0% - Exclusive Study by Transparency Market Research
October 19, 2023 11:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global non-invasive cancer diagnostics market is projected to flourish at a CAGR of 7.0%...
Global Radiopharmaceuticals Strategic Analysis Report 2023: Market to Reach $14.3 Billion by 2030 - Emergence of Radiotheranostics as Dual-Functioning Radiopharmaceuticals Bolsters Growth
October 09, 2023 05:48 ET
|
Research and Markets
Dublin, Oct. 09, 2023 (GLOBE NEWSWIRE) -- The "Radiopharmaceuticals - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Radiopharmaceuticals Market...
Nuclear Medicine Market to Hit USD 25 Mn | Innovations and Insights into Diagnostic Advancements (2023-2032)
September 15, 2023 06:25 ET
|
Market.Us
New York, Sept. 15, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Market.us, the Global Nuclear Medicine Market size is expected to be worth around USD 25 Million by 2032 from USD 7.0...
Curium Announces Exclusive Distribution Agreement in Switzerland with b.e. Imaging for PYLCLARI™, an Innovative 18F-PSMA Pet Tracer Indicated in Adults with Prostate Cancer
September 07, 2023 04:25 ET
|
Curium
PARIS, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that it has entered into an exclusive rights agreement with b.e. Imaging, for the distribution...
Nuclear Medicine Global Market Report 2023: Bone Density Scanning and Cardiac PET Sarcoid Drive Market, Key Players are Advanced Accelerator Applications, The institute for Radioelement
August 16, 2023 04:54 ET
|
Research and Markets
Dublin, Aug. 16, 2023 (GLOBE NEWSWIRE) -- The "Nuclear Medicine Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.This comprehensive report provides valuable...
Curium Announces Achievement of Co-Primary Endpoints in Phase 2 of Its Phase 1/2 SOLAR Clinical Trial Imaging Men With Histologically-Proven Prostate Cancer Using Copper Cu 64 PSMA I&T
August 15, 2023 10:50 ET
|
Curium
PARIS, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today the positive results of the multi-center, open-label, Phase 2 SOLAR study of Copper Cu 64 PSMA...
Nuclear Medicine Market Size to Surpass USD 29.35 Billion by 2030, exhibiting a CAGR of 19.5%
August 10, 2023 07:28 ET
|
Fortune Business Insights
Pune, India, Aug. 10, 2023 (GLOBE NEWSWIRE) -- The global nuclear medicine market size was valued at USD 7.53 billion in 2022. The market is projected to grow from USD 8.42 billion in 2023 to USD...
Curium Receives Marketing Authorization in the EU for PYLCLARI™, an Innovative 18F-PSMA PET Tracer Indicated in Adults With Prostate Cancer
July 28, 2023 06:12 ET
|
Curium
PARIS, July 28, 2023 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced that the European Commission has granted marketing authorization for PYLCLARI™ (INN: Piflufolastat...